AI assistant
Sending…
BioCardia, Inc. — Director's Dealing 2016
Oct 26, 2016
35081_dirs_2016-10-26_bbf28be2-cfc2-4534-a89d-82b08335cb9b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: BioCardia, Inc. (BCDA)
CIK: 0000925741
Period of Report: 2016-10-24
Reporting Person: Altman Peter (Director, President and CEO)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 8338109 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Employee stock option (right to buy) | $0.1500 | 2018-06-19 | Common Stock (941894) | Direct | |
| Employee stock option (right to buy) | $0.1500 | 2020-04-10 | Common Stock (81460) | Direct | |
| Employee stock option (right to buy) | $0.1500 | 2024-07-05 | Common Stock (3811370) | Direct | |
| Employee stock option (right to buy) | $0.1500 | 2026-08-19 | Common Stock (14520098) | Direct |
Footnotes
F1: The shares subject to the option are fully vested and immediately exercisable.
F2: One-forty-eighth of the shares subject to the option vest on August 1, 2014 and each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.
F3: One-forty-eighth of the shares subject to the option vest on November 24, 2016 and each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.
More from BioCardia, Inc.
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 21
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 8
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 20
Regulatory Filings
2026
Apr 15
Regulatory Filings
2026
Apr 2
Director's Dealing
2026
Mar 27